338 related articles for article (PubMed ID: 35324035)
1. Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan.
Adomi M; Kuno T; Komiyama J; Taniguchi Y; Abe T; Miyawaki A; Imai S; Morita K; Saito M; Ohbe H; Kamio T; Tamiya N; Iwagami M
Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):680-688. PubMed ID: 35324035
[TBL] [Abstract][Full Text] [Related]
2. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation.
Poletto F; Spiezia L; Simion C; Campello E; Dalla Valle F; Tormene D; Camporese G; Simioni P
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458467
[TBL] [Abstract][Full Text] [Related]
4. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.
Parks AL; Auerbach AD; Schnipper JL; Bertram A; Jeon SY; Boyle B; Fang MC; Gadrey SM; Siddiqui ZK; Brotman DJ;
PLoS One; 2022; 17(5):e0266944. PubMed ID: 35511940
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
Shaw JR; Douketis J; Le Gal G; Carrier M
J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
[TBL] [Abstract][Full Text] [Related]
8. Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden.
Balabanova Y; Farahmand B; Stattin P; Garmo H; Brobert G
BMC Urol; 2022 Feb; 22(1):15. PubMed ID: 35109829
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.
Yamashita Y; Amano H; Morimoto T; Kadota K; Hata R; Matsushita K; Osakada K; Sano A; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Inoko M; Tada T; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
J Thromb Thrombolysis; 2022 Jan; 53(1):182-190. PubMed ID: 34228248
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry.
Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with venous thromboembolism and COVID-19: Analysis of risk factors for death and major bleeding.
Demelo-Rodríguez P; Ordieres-Ortega L; Ji Z; Del Toro-Cervera J; de Miguel-Díez J; Álvarez-Sala-Walther LA; Galeano-Valle F
Eur J Haematol; 2021 May; 106(5):716-723. PubMed ID: 33608914
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants.
Kaneda K; Yamashita Y; Morimoto T; Chatani R; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Kimura T;
Eur J Intern Med; 2023 Dec; 118():59-72. PubMed ID: 37574348
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
[TBL] [Abstract][Full Text] [Related]
15. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
Jiménez D; García-Sanchez A; Rali P; Muriel A; Bikdeli B; Ruiz-Artacho P; Le Mao R; Rodríguez C; Hunt BJ; Monreal M
Chest; 2021 Mar; 159(3):1182-1196. PubMed ID: 33217420
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of the Kuijer score for bleeding and other adverse in-hospital events in patients with venous thromboembolism.
Keller K; Münzel T; Hobohm L; Ostad MA
Int J Cardiol; 2021 Apr; 329():179-184. PubMed ID: 33301828
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.
Wang L; Zhao L; Li F; Liu J; Zhang L; Li Q; Gu J; Liang S; Zhao Q; Liu J; Xu JF
Clin Respir J; 2022 Mar; 16(3):182-189. PubMed ID: 35060325
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study.
Lee Y; Jehangir Q; Li P; Gudimella D; Mahale P; Lin CH; Apala DR; Krishnamoorthy G; Halabi AR; Patel K; Poisson L; Balijepally V; Sule AA; Nair GB
BMC Infect Dis; 2022 May; 22(1):462. PubMed ID: 35562677
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status.
Li W; Xu Z; Xiang H; Zhang C; Guo Y; Xiong J
Aging (Albany NY); 2021 Mar; 13(7):9225-9242. PubMed ID: 33818421
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
